Advisor Group Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 9,342 shares of REGN stock, worth $6.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,342

Previous 7,925 17.88%

Holding current value

$6.4 Million

Previous $8.33 Million 17.9%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $1.45 Million - $1.7 Million	1,417 Added 17.88%	9,342 $9.82 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $2.1 Million - $2.54 Million	-2,374 Reduced 23.05%	7,925 $8.33 Million
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $4.78 Million - $5.26 Million	-5,299 Reduced 33.97%	10,299 $9.91 Million
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $1.91 Million - $2.18 Million	-2,470 Reduced 13.67%	15,598 $13.7 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $5.34 Million - $6.51 Million	7,711 Added 74.45%	18,068 $14.9 Million
Q2 2023 Aug 21, 2023	SELL	$700.03 - $830.35 $18.6 Million - $22 Million	-26,549 Reduced 71.94%	10,357 $7.44 Million
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $18.5 Million - $21.9 Million	26,414 Added 251.75%	36,906 $26.5 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $1.12 Million - $1.36 Million	-1,644 Reduced 13.55%	10,492 $8.62 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $2.28 Million - $2.47 Million	-3,223 Reduced 20.98%	12,136 $8.76 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $308,795 - $389,684	538 Added 3.63%	15,359 $10.6 Million
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $1.48 Million - $1.99 Million	-2,691 Reduced 15.37%	14,821 $8.77 Million
Q1 2022 May 04, 2022	BUY	$595.12 - $698.43 $3.53 Million - $4.14 Million	5,930 Added 51.2%	17,512 $11.6 Million
Q3 2021 Nov 05, 2021	BUY	$574.03 - $680.96 $490,795 - $582,220	855 Added 7.97%	11,582 $7 Million
Q2 2021 Aug 02, 2021	BUY	$472.8 - $558.54 $456,724 - $539,549	966 Added 9.9%	10,727 $5.99 Million
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $222,024 - $272,455	-497 Reduced 4.84%	9,761 $4.62 Million
Q4 2020 Feb 10, 2021	SELL	$478.3 - $607.98 $62,179 - $79,037	-130 Reduced 1.25%	10,258 $4.95 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $3.37 Million - $4.08 Million	-6,192 Reduced 37.35%	10,388 $5.82 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $25.4 Million - $33.1 Million	-51,451 Reduced 75.63%	16,580 $10.3 Million
Q1 2020 May 18, 2020	BUY	$336.18 - $494.43 $22.9 Million - $33.6 Million	68,031 New	68,031 $6.01 Million

Others Institutions Holding REGN

# of Institutions

1,497

Shares Held

82.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History